Drug release from injectable depots: Two different in vitro mechanisms

Journal of Controlled Release

Volumn 99, Issue 2, 2004, Pages 207-216

  Wang, Liwei ^a   Venkatraman, Subbu ^a   Kleiner, Lothar ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Benzyl benzoate (BB); Gelation; In vitro; Metoclopramide; Poly (lactide co glycolide) (PLGA)

Indexed keywords

BENZYL BENZOATES; BUFFER INJECTION; GEL PERMEATION CHROMATOGRAPHY (GPC); LACTIDES;

CATALYSIS; CONCENTRATION (PROCESS); EROSION; GELS; HYDROLYSIS; MOLECULAR WEIGHT; POLYMERS; RHEOLOGY; VISCOSITY;

DRUG INFUSION;

A137 28; A137 29; A137 31; APT071603 1; BASE; BENZYL BENZOATE; BUFFER; GLYCOSIDE; POLYGLACTIN; PURASORB DL 655FK; PURASORB PDLG; RESOMER RG502; RESOMER RG502H; SOLVENT; UNCLASSIFIED DRUG; WATER;

ARTICLE; CATALYSIS; CONTROLLED DRUG RELEASE; DIFFUSION; EROSION; FLOW KINETICS; GEL; GEL PERMEATION CHROMATOGRAPHY; HYDROLYSIS; IN VITRO STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; VISCOSITY;

BENZOATES; BUFFERS; CHROMATOGRAPHY, GEL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; GELS; INJECTIONS; LACTIC ACID; METOCLOPRAMIDE; MOLECULAR WEIGHT; POLYGLYCOLIC ACID; POLYMERS; PYRROLIDINONES; RHEOLOGY; SOLUBILITY; SOLUTIONS; TECHNOLOGY, PHARMACEUTICAL; VISCOSITY;

EID: 4544224331     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.06.021     Document Type: Article

References (26)

1. R.L. Dunn, J.P. English, D.R. Cowsar, D.P. Vanderbilt, Biodegradable in-situ forming implants and methods of producing the same, U.S. Patent 4,938.763, July 3, 1990.
2. R.L. Dunn, A.J. Tipton, Polymeric compositions used as controlled release implants, U.S. Patent 5,702,716, Dec. 30, 1997.
3. R.E. Eliaz et al., Composition and method for forming biodegradable implants in situ and uses of these implants, U.S. Patent 6,206,920, Mar. 27, 2001.
4. R.L. Dunn, G.L. Yewey, S.M. Fujita, K.R. Josephs, S.L. Whitman, and G.L. Southard Sustained release of cisplatin in dogs from an injectable implant delivery system J. Bioact. Compat. Polym. 11 1996 286 300
5. P.D. Graham, K.J. Brodbeck, and A.J. Mchugh Phase inversion dynamics of PLGA solutions related to drug delivery J. Control. Release 58 1999 233 245
6. K.J. Brodbeck, J.R. Desnoyer, and A.J. Mchugh Phase inversion dynamics of PLGA solutions related to drug delivery: Part II. The role of solution thermodynamics and bath-side mass transfer J. Control. Release 62 1999 333 344
7. R.E. Eliaz, and J. Kost Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins J. Biomed. Materi. Res. 50 2000 388 396
8. R.E. Eliaz, D. Wallach, and J. Kost Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants in-vivo Pharm. Res. 17 2000 1546 1550
9. U.V. Singh, K.S. Bisht, S. Rao, P. Uma Devi, and N. Udupa Reduced toxicity and enhanced antitumor efficacy of plambagin using poly (lactic-co-glycolic) biodegradable injectable implant Indian J. Pharmacol. 29 1997 168 172
10. M.L. Shively, B.A. Coonts, W.D. Renner, J.L. Southard, and A.T. Bennett Physico-chemical characterization of a polymeric injectable implant delivery system J. Control. Release 33 1995 237 243
11. J.R. DesNoyer, and A.J. McHugh Role of crystallization in the phase inversion dynamics and protein release kinetics of injectable drug delivery systems J. Control. Release 70 2001 285 294
12. R.L. Dunn, J.P. English, and J.D. Strobel Preparation and evaluation of lactide/glycolide copolymers for drug delivery Polym. Med. 3C 1988 149 160
13. H.B. Ravivarapu, K.L. Moyer, and R.L. Dunn Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant AAPS PharmSciTech 1 2000
14. K.J. Brodbeck, S. Pushpala, and A.J. McHugh Sustained release of human growth hormone from PLGA solution depots Pharm. Res. 16 1999 1825 1829
15. J.R. DesNoyer, and A.J. McHugh Role of crystallization in the phase inversion dynamics and protein release kinetics of injectable drug delivery systems J. Control. Release 70 2001 285 294
16. W.J. Lambert, and K.D. Peck Development of an in situ forming biodegradable poly-lactide-co-glycolide system for the controlled release of proteins J. Control. Release 33 1995 189 195
17. R.A. Jain, C.T. Rhodes, A.M. Railkar, A.W. Malick, and N.H. Shah Comparison of various injectable protein-loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices: in-situ-formed implant versus in-situ-formed microspheres versus isolated microspheres Pharm. Dev. Technol. 5 2000 201 207
18. L. Wang, L. Kleiner, and S. Venkatraman Structure formation in injectable poly (lactide-co-glycolide) depots J. Control. Release 90 2003 345 354
19. S.M. Li, S. Girod-Holland, and M. Vert Hydrolytic degradation of poly (dl-lactic acid) in the presence of caffeine base J. Control. Release 40 1996 41 53
20. H. Maulding, T. Tice, D. Cowsar, J. Fong, J. Pearson, and J. Nazareno J. Control. Release 3 1986 103
21. A. Kishida, S. Yoshioka, Y. Takeda, and M. Uchiyama Formulation-assisted biodegradable polymer matrices Chem. Pharm. Bull. 37 1989 1954 1956
22. J.M. Guenet, N.F.F. Willmott, and P.A. Ellsmore Polym. Commun. 16 1983 28
23. K.J. Brodbeck, A.Gaynor-Duarte, T. Shen, Gel composition and methods, US Patent 6,130,200, October 10, 2000.
24. B. Narasimhan Accurate models in controlled drug delivery systems Handbook of Pharmaceutical Controlled Release Technology 2000 Marcel Dekker New York 155 181
25. T. Higuchi Rate of release of medicaments from ointment bases containing drugs in suspension J. Pharm. Sci. 50 1961 874 875
26. D.R. Paul, and S.K. McSpadden Diffusional release of a solute from a polymer matrix J. Membr. Sci. 1 1976 33 48